EK - Local Recommendations (SGLT2i)

Use documents past their review date with caution

Recommendation Approval date Review date
Kent and Medway SGLT2i Top Tips October 2023 October 2025
NICE TA 942 - Empagliflozin for treating chronic kidney disease April 2024 April 2026
SGLT2is and Finerenone for Chronic Kidney Disease in Adults – Primary Care Guidance June 2024 June 2026
  • On Formulary Preferred
  • On Formulary Second Line
  • On Formulary Third Line
  • Specialist Initiation
  • Secondary Care Only
  • Not Approved for Formulary